Buscar | Meisterbook

agregó una foto Health

2026-07-17 09:26:06 -

Erythromelalgia Treatment Market: Why Does a Genetically Identified Disease Still Have No Approved Targeted Drug?

The erythromelalgia treatment market — therapies for a rare neurovascular pain disorder characterized by episodic burning pain, redness, and elevated skin temperature in the extremities, frequently linked to gain-of-function mutations in sodium channel genes — remains a small but steadily growing niche within rare disease pharmaceuticals, with the Erythromelalgia Treatment Market...

0 Commentarios 0 Acciones 2 Views 0 Vista previa